It is well-known that euglycemic diabetic ketoacidosis is the fatal side effect of SGLT2 inhibitors, which might occur on a sick day (Ogawa and Sakaguchi, 2016). This evidence concerns the gene SLC5A2 and diabetic ketoacidosis.